GET THE APP
ISSN: 2169-0138
Department of Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Boston, USA
Commentary A Note on Bridging Study Design and Analysis Author(s): Mario Nagase* DOI: 10.35248/2169-0138.22.11.219
HTML PDF